MAPT and amyloidosis: The latter result supports our in vivo observation and is compatible with the hypothesis that intravenously injected PHF-tau proteins entering into the brain through increased blood–brain barrier permeability could induce the increased amyloid burden observed in 5XFAD injected mice.